![Percutaneous autologous bone marrow concentrate for knee osteoarthritis: patient-reported outcomes and progenitor cell content | SpringerLink Percutaneous autologous bone marrow concentrate for knee osteoarthritis: patient-reported outcomes and progenitor cell content | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00264-022-05524-9/MediaObjects/264_2022_5524_Fig2_HTML.png)
Percutaneous autologous bone marrow concentrate for knee osteoarthritis: patient-reported outcomes and progenitor cell content | SpringerLink
![Percutaneous autologous bone marrow concentrate for knee osteoarthritis: patient-reported outcomes and progenitor cell content | SpringerLink Percutaneous autologous bone marrow concentrate for knee osteoarthritis: patient-reported outcomes and progenitor cell content | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00264-022-05524-9/MediaObjects/264_2022_5524_Fig1_HTML.png)
Percutaneous autologous bone marrow concentrate for knee osteoarthritis: patient-reported outcomes and progenitor cell content | SpringerLink
![Percutaneous autologous bone marrow concentrate for knee osteoarthritis: patient-reported outcomes and progenitor cell content | SpringerLink Percutaneous autologous bone marrow concentrate for knee osteoarthritis: patient-reported outcomes and progenitor cell content | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00264-022-05524-9/MediaObjects/264_2022_5524_Fig4_HTML.png)